Skip to content

The correlation between probiotics and anxiety and depression levels in cancer patients: a retrospective cohort study

The correlation between probiotics and anxiety and depression levels in cancer patients: a retrospective cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047620
Enrollment
Unknown
Registered
2021-06-20
Start date
2021-06-21
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

taking probiotics group:Nil
not taking probiotics group:Nil

Sponsors

The First Affiliated Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18-70 years, no gender limit; 2. Diagnosed with tumor; 3. Use intestinal microecological preparations, mainly including Miya tablets, compound Lactobacillus acidophilus tablets, Meichangan capsules, Bifikang capsules, mosapride and itopride, etc.; 4. ECOG score of 0 or 1; 5. The patient can communicate and communicate normally, has at least primary school education level, and can understand daily expressions.

Exclusion criteria

Exclusion criteria: 1. Life expectancy is less than 6 months; 2. Those with a history of mental disorders, cognitive disorders, or unable to make normal judgments about things; 3. There are obvious symptoms of brain metastases; 4. The cumulative use time of intestinal microecological preparations is less than 1 week; 5. Patients judged by the investigator to be unsuitable for enrollment.

Design outcomes

Primary

MeasureTime frame
anxiety level;depression level;

Countries

China

Contacts

Public ContactYang Si
yangsi@zju.edu.cn+86 571 87233411

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026